Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Two Lots of Zoledronic Acid Injection, 5mg/100mL due to Potential Lack of Container Integrity SCHAUMBURG, Ill., March 4, 2014 (GLOBE ...

The researchers found that 6.3, 6.6, and 11.1% of the zoledronate-zoledronate, zoledronate-placebo, and placebo-placebo groups, respectively, had a new morphometric fracture at follow-up. HealthDay ...

MONTREAL, QUEBEC — Women age 65 years and older who had osteopenia and received an injection of zoledronate every 18 months for 6 years had a 37% lower rate of fractures than those who received ...

Zoledronate prevents fractures in older women when administered every 12 to 18 months, but its effects on bone density and bone turnover persist beyond 5 years. Whether infrequent zoledronate ...

Credit: Shutterstock. The researchers found that a fragility fracture occurred in 190 women in the placebo group and 122 women in the zoledronate group (hazard ratio [HR] with zoledronate, 0.63).

Exclusion criteria were a T score of −2.5 or less at any of these sites, any major systemic illness or metabolic bone disease, a previous clinical spine or hip fracture, use of any bisphosphonates or ...